日本語
TOP page
Published papers
Academic conference presentation
(Last updated : 2024-09-19 15:32:44)
Okamoto Yuuko
Department
School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Rheumatology
Position
Assistant Professor
■
Published papers
1.
Other
Reply. 2022/03/18
2.
Original article
Association of Sputum Neutrophil Extracellular Trap Subsets With IgA Anti-Citrullinated Protein Antibodies in Subjects at Risk for Rheumatoid Arthritis. 2022/01/01
3.
Original article
Validation of the Japanese version of the Lupus Damage Index Questionnaire in a large observational cohort: A two-year prospective study. 2021/07/04
4.
Original article
Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14hi monocytes. 2021/02
5.
Original article
Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods. 2020/03
6.
Original article
Clinical usefulness of anti-M-type phospholipase-A-recepter antibodies in patients with membranous nephropathy and the comparison of three quantification methods. 2020/01/07
7.
Original article
Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction. 2018/09
8.
Original article
Anti-MDA5 antibody, ferritin and IL-18 are useful for the evaluation of response to treatment in interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis. 2012/09
9.
Original article
Clinical manifestations of neurological involvement in primary Sjögrens syndrome. 2011/04
10.
Original article
Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. 2010/10
11.
Original article
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. 2010/09
12.
Original article
Clinical images: Dramatic amelioration of pneumatosis cystoides intestinalis in systemic sclerosis. 2010/04
Display 5 items
Display all(12)
■
Academic conference presentation
1.
Serum From Patients with SLE And Anti-MDA5 Antibody Positive Dermatomyositis Induce Shared Monocyte Cytokine Signature Through Type 1 2022/11/13
2.
Analysis Of Relationship Between Clinical Manifestations and Autoantibody Profile In ISN/RPS Class V Lupus Nephritis 2013/10
3.
Pirfenidone and BIBF1120 Suppress Collagen Synthesis In Skin Fibroblast From Patients With Systemic Sclerosis 2013/10
4.
line blot assay (LBA), a screening test for autoantibodies in systemic sclerosis (SSc) 2012/11
5.
Urinary λ Free Light Chain Concentration Is Associated with Disease Activity and Response to Treatment in Proliferative Lupus Nephritis 2011/11
6.
Anti-C1q Antibodies Are Associated with Global Activity of Systemic Lupus Erythematosus, but Not Specifically with Nephritis. 2010/11/09
7.
Predominant Suppression of Plasmablasts by Cyclophosphamide in Patients with Systemic Lupus Erythematosus: A Possible Therapeutic Mechanism. 2010/11/09
8.
Association of Low-dose Pulsed Intravenous Cyclophosphamide Therapy and Amenorrhea in 62 patients with Systemic Lupus Erythematosus: A Case-control Study. 2010/11/08
9.
Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. 2010/11
10.
Interleukin-18 is a key mediator in dermatomyositis: potential contribution to development of interstitial lung disease. 2010/11
Display 5 items
Display all(10)